Total Payments
$7,919
2024 Payments
$1,390
Companies
23
Transactions
411
Medicare Patients
3,563
Medicare Billing
$4.2M
Payment Breakdown by Category
Food & Beverage$7,405 (93.5%)
Education$513.96 (6.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,405 | 405 | 93.5% |
| Education | $513.96 | 6 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,050 | 101 | $0 (2024) |
| Amgen Inc. | $966.90 | 46 | $0 (2024) |
| Janssen Biotech, Inc. | $771.71 | 44 | $0 (2024) |
| GlaxoSmithKline, LLC. | $724.14 | 24 | $0 (2024) |
| Genentech USA, Inc. | $625.68 | 33 | $0 (2018) |
| PFIZER INC. | $547.82 | 46 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $442.80 | 29 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $355.61 | 4 | $0 (2024) |
| UCB, Inc. | $287.48 | 10 | $0 (2024) |
| Mallinckrodt LLC | $153.92 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,390 | 48 | ABBVIE INC. ($306.06) |
| 2023 | $794.65 | 34 | ABBVIE INC. ($304.88) |
| 2022 | $617.02 | 23 | ABBVIE INC. ($308.12) |
| 2021 | $40.64 | 3 | AbbVie Inc. ($28.63) |
| 2020 | $80.63 | 1 | AbbVie Inc. ($80.63) |
| 2019 | $126.01 | 2 | AbbVie, Inc. ($95.52) |
| 2018 | $2,147 | 119 | AbbVie, Inc. ($411.79) |
| 2017 | $2,722 | 181 | AbbVie, Inc. ($514.55) |
All Payment Transactions
411 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.32 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.06 | General |
| Category: Immunology | ||||||
| 11/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $79.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $132.57 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $108.59 | General |
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $110.73 | General |
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $4.39 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $41.45 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: Immunology | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $14.31 | General |
| Category: Immunology | ||||||
| 10/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $9.33 | General |
| Category: Immunology | ||||||
| 09/10/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $4.00 | General |
| Category: Immunology | ||||||
| 09/04/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,139 | 59,202 | $2.1M | $1.1M |
| 2022 | 19 | 1,014 | 57,714 | $2.6M | $1.1M |
| 2021 | 17 | 698 | 41,130 | $2.2M | $1.0M |
| 2020 | 18 | 712 | 32,597 | $1.9M | $978,830 |
Total Patients
3,563
Total Services
190,643
Medicare Billing
$4.2M
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 41 | 42,835 | $865,728 | $449,881 | 52.0% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 14 | 11,075 | $715,223 | $371,910 | 52.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 324 | 794 | $160,388 | $77,540 | 48.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 28 | 2,700 | $95,676 | $50,051 | 52.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 137 | 137 | $47,561 | $23,021 | 48.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 144 | 161 | $45,500 | $22,600 | 49.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 77 | 394 | $50,428 | $21,253 | 42.1% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2023 | 11 | 29 | $31,071 | $16,219 | 52.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 49 | 120 | $25,257 | $13,067 | 51.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 64 | 124 | $15,486 | $7,251 | 46.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $14,481 | $6,681 | 46.1% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 35 | 96 | $11,278 | $5,592 | 49.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 28 | $4,008 | $1,874 | 46.7% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2023 | 15 | 30 | $3,219 | $1,493 | 46.4% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 17 | 85 | $1,063 | $555.84 | 52.3% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2023 | 39 | 103 | $946.12 | $472.79 | 50.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 42 | 386 | $623.50 | $317.77 | 51.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 24 | $538.20 | $223.06 | 41.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 14 | 26 | $303.45 | $158.57 | 52.3% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2022 | 43 | 41,772 | $1.4M | $495,495 | 35.9% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 19 | 12,475 | $854,521 | $432,125 | 50.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 264 | 526 | $103,909 | $51,870 | 49.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 17 | 1,380 | $43,139 | $23,688 | 54.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 124 | 142 | $39,917 | $21,499 | 53.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 56 | 190 | $50,083 | $20,433 | 40.8% |
About Dr. Thais Moldovan, M.D
Dr. Thais Moldovan, M.D is a Internal Medicine healthcare provider based in Newtown Square, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2009. The National Provider Identifier (NPI) number assigned to this provider is 1699902643.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thais Moldovan, M.D has received a total of $7,919 in payments from pharmaceutical and medical device companies, with $1,390 received in 2024. These payments were reported across 411 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($7,405).
As a Medicare-enrolled provider, Moldovan has provided services to 3,563 Medicare beneficiaries, totaling 190,643 services with total Medicare billing of $4.2M. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Newtown Square, PA
- Active Since 06/17/2009
- Last Updated 02/01/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1699902643
Products in Payments
- Humira (Biological) $897.82
- Enbrel (Biological) $675.89
- RINVOQ (Biological) $644.13
- BENLYSTA (Biological) $604.27
- Rituxan (Biological) $512.42
- XELJANZ (Drug) $494.02
- TREMFYA (Drug) $384.80
- ORENCIA (Biological) $332.07
- SIMPONI ARIA (Biological) $321.32
- SKYRIZI (Biological) $303.56
- Cimzia (Drug) $287.48
- SAPHNELO (Biological) $247.02
- TAVNEOS (Drug) $160.74
- ACTHAR (Biological) $153.92
- EVENITY (Biological) $130.27
- Rasuvo (Drug) $125.47
- COSENTYX (Biological) $114.64
- Actemra (Biological) $113.26
- Rinvoq (Biological) $95.52
- RAYOS (Drug) $94.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newtown Square
Joseph Reitano, Md, MD
Internal Medicine — Payments: $3,081
Internal Medicine $3,081
Shinette Sirmans-Mcrae, M.d, M.D
Internal Medicine — Payments: $403.53
Internal Medicine $403.53
Madeleine Heaney, Md, MD
Internal Medicine — Payments: $180.21
Internal Medicine $180.21
Dr. Thomas Lawrence, Md, MD
Internal Medicine — Payments: $126.20
Internal Medicine $126.20
James Harkins, Md, MD
Internal Medicine — Payments: $93.61
Internal Medicine $93.61
Praphulla Hebbalalu, M.d, M.D
Internal Medicine — Payments: $78.32
Internal Medicine $78.32